Tyler Sean Auschwitz

Tyler Auschwitz practices at Ascension St. John Medical Center in Tulsa, Oklahoma, part of Ascension Health Alliance.

Tyler Auschwitz's NPI, 1003050493, was assigned on April 29, 2009. Tyler Auschwitz holds Oklahoma license 31242.

Tyler Auschwitz's primary practice is Ascension St. John Medical Center, at 1923 South Utica Avenue, Tulsa, OK 74104 in Tulsa County. The practice phone is (918) 744-2296.

Tyler Auschwitz's primary practice is Ascension St. John Medical Center in Tulsa, Oklahoma, part of Ascension Health Alliance. Tyler Auschwitz is also affiliated with Cherokee Nation W. W. Hastings Hospital. The medical group on file is Ascension St. John. Dmand AI also links Tyler Auschwitz to 2 more hospitals, 1 home health agency and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tyler Auschwitz practices, 6 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Tyler Auschwitz's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Tyler Auschwitz is board certified in neurological surgery by the American Board of Neurological Surgery. Tyler Auschwitz is licensed in Oklahoma.

CMS data shows 1,131 Medicare services from Tyler Auschwitz across 22 procedure codes in 2024, for 520 Medicare patients. Medicare paid $227,473 for them.

CMS counts 520 Medicare patients who saw Tyler Auschwitz in 2024. The largest group is 65 to 74, with 216 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tyler Auschwitz's median patient age at 64, with 51% women.

In 2024, Tyler Auschwitz wrote 121 Medicare Part D claims for 75 patients. 100% of them were for generic drugs. CMS names the drug for 111 of them, across 3 drugs with 11 or more claims each, at $786 in total drug cost. In 2023, CMS named 88 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Tyler Auschwitz for performance year 2024, reported through an alternative payment model (APM). Tyler Auschwitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 253 procedures of spinal fusion by Tyler Auschwitz, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Tyler Auschwitz, published from 2013 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Craniotomy. Tyler Auschwitz has published most often in World Neurosurg. Tyler Auschwitz's most frequent co-authors are Brandon King, DO, Frederick A. Boop, MD and Nickalus R. Khan, MD.

Dmand AI links Tyler Auschwitz to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 224 general payments to Tyler Auschwitz from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Penumbra, Inc. paid the most, $13,582.